📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
FREDUN PHARMACEUTICALS LIMITEDFREDUNPharmaceuticals
Open
2910
High
2910
Low
2789
Close
2826.6
Volume
17813
Exchange
bse
Time
15-Jul-2026

Outlook

Score:  

5.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Fredun Pharmaceuticals is  
None
Estimated Stoploss of Fredun Pharmaceuticals is ₹  
2910
Fredun Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Fredun Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Fredun Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Fredun Pharmaceuticals is  
Upℹ
 by  

12.91

%. 
Target
Buy @ 

1868.89

Sell @ 

2894.21

Current @ 

2826.6

Volume

Fredun Pharmaceuticals has seen  
Moderateℹ
 volume of trades. 
Though the volume trend for Fredun Pharmaceuticals appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Fredun Pharmaceuticals is  

Up

 by  

23.81

% 

Valuation

The current market price of Fredun Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 486cr and total assets worth ₹ 486cr, the balance sheet of Fredun Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Fredun Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 3cr

. It is  
Upℹ
 by  

250

%. 

(*Mar 2025)

39.44% i.e. ₹ 28cr spent in operatingℹ
7.04% i.e. ₹ 5cr spent in investingℹ
53.52% i.e. ₹ 38cr earned in financingℹ
0% in otherℹ
Fredun Pharmaceuticals has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 2cr

. It is  
Downℹ
 by  

300

%. 

(*Mar 2024)

0% in operatingℹ
58.33% i.e. ₹ 7cr spent in investingℹ
41.67% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Income
The income of Fredun Pharmaceuticals is  

₹ 167cr

 and  

Profit

 is :  

₹ 7cr

(*Mar 2025)

Fredun Pharmaceuticals Profit is up by:  

40

% and Income is Up by:  

63.73

% 

(*Mar 2025)

The income of Fredun Pharmaceuticals is  

₹ 102cr

 and  

Profit

 is :  

₹ 5cr

(*Dec 2024)

Fredun Pharmaceuticals Profit is up by:  

25

% and Income is Down by:  

4.67

% 

(*Dec 2024)

The income of Fredun Pharmaceuticals is  

₹ 107cr

 and  

Profit

 is :  

₹ 4cr

(*Sep 2024)

Fredun Pharmaceuticals Profit is up by:  

0

% and Income is Up by:  

37.18

% 

(*Sep 2024)

Market Cap

Market capital of Fredun Pharmaceuticals Limited is 810cr

Top Rated Competitors

NameScore
RPG Life Sciences Limited
6
BDH Industries Ltd.
6
KIMIA BIOSCIENCES LIMITED
5.75
Marksans Pharma Ltd.
5.75
Pfizer Ltd.
5.5
Abbott India Ltd.
5.5
Kilitch Drugs (I) Ltd.
5.5
Lactose (India) Ltd.
5.25
Lupin Ltd
5.25
By using this site you agree to the use of cookies to deliver a better site experience.